{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-039359","form_type":"8-K","ticker":"ZVIA","cik":"0001854139","company_name":"Zevia PBC","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.792791+00:00","generated_at":"2026-06-12T02:53:29.286078+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zevia Q2 net sales down 7.2% to $42.2M; net loss narrows to $5.0M","bullets":["Net sales $42.2M (-7.2% YoY), unit volume down 16.8% to 3.3M cases.","Gross margin 46.6% (+4.2 pp YoY), strongest as a public company.","Net loss $5.0M vs $14.8M YoY; loss per share $0.08.","Adjusted EBITDA loss $2.6M, improved from $6.4M loss a year ago.","Maintains 2023 guidance: net sales $163-168M; Q3 expected $38-41M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-039359","json":"https://secwatch.observer/filing/0000950170-23-039359.json","markdown":"https://secwatch.observer/filing/0000950170-23-039359.md","text":"https://secwatch.observer/filing/0000950170-23-039359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023039359/0000950170-23-039359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023039359/zvia-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T02:53:29.286078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cce07effe0d49790a4ce8facb322baa3dca34a8d","claim":"Zevia PBC reported second quarter ended June 30, 2023 results: revenue $42.2 million, net income $5.0 million, EPS $0.08 per diluted share. Guidance reaffirmed.","evidence_excerpt":"simple, plant-based ingredients, today reported results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights • Net sales decreased 7.2% year over year to $42.2 million • Unit volume decreased 16.8% year over year to 3.3 million equivalized cases • Gross profit margin of 46.6%, up 4.2 percentage points year over year, and the strongest gross","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023039359/0000950170-23-039359-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$42.2 million"},{"label":"Net income","value":"$5.0 million"},{"label":"EPS","value":"$0.08 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}